Matches in Wikidata for { <http://www.wikidata.org/entity/Q65357322> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q65357322 description "clinical trial" @default.
- Q65357322 description "ensayu clínicu" @default.
- Q65357322 description "klinisch onderzoek" @default.
- Q65357322 description "клінічне випробування" @default.
- Q65357322 name "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 name "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 type Item @default.
- Q65357322 label "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 label "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 prefLabel "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 prefLabel "Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects." @default.
- Q65357322 P1132 Q65357322-C8EC3087-2C33-48AE-908F-F47F0F681710 @default.
- Q65357322 P1476 Q65357322-4D7664A8-EC33-4C10-A1D0-8587318ED94C @default.
- Q65357322 P17 Q65357322-0D97F826-C240-4D90-A5E0-08389C26CF9C @default.
- Q65357322 P17 Q65357322-50DF585D-51C2-401D-8E56-E7EBF77DA3A5 @default.
- Q65357322 P17 Q65357322-AAB8E17D-3585-4B78-8CA8-D7CAB6904744 @default.
- Q65357322 P17 Q65357322-DF54F36F-3A17-444F-9B23-B224769E7B31 @default.
- Q65357322 P2899 Q65357322-290B3BFA-E49D-4840-90A5-0023BA8D07ED @default.
- Q65357322 P3098 Q65357322-F616D996-CEAD-4F7D-8D34-036B5A31C776 @default.
- Q65357322 P31 Q65357322-FEE1A66A-7882-4E19-8E01-E14C81004F80 @default.
- Q65357322 P4135 Q65357322-6D8ADFDB-3C5F-4845-A95B-861A5C7B883B @default.
- Q65357322 P580 Q65357322-BDF9C108-5572-4A51-9CE4-6C2A8674A36D @default.
- Q65357322 P582 Q65357322-9365DA30-26E6-474C-91F9-D5E9C7A3A1A9 @default.
- Q65357322 P6099 Q65357322-6EFE76AF-B7C1-4AFC-A621-D7074E61D407 @default.
- Q65357322 P8363 Q65357322-4C6F5A55-FB25-4A09-80EE-2CA6D5880912 @default.
- Q65357322 P1132 "+239" @default.
- Q65357322 P1476 "A Phase IIIb, Open Label, Controlled, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Doses of Novartis Meningococcal Group B Vaccine When Administered to Immunocompromised Patients From 2 to 17 Years of Age Who Are at Increased Risk of Meningococcal Disease Because of Complement Deficiency or Asplenia Compared to Matched Healthy Controls." @default.
- Q65357322 P17 Q145 @default.
- Q65357322 P17 Q29 @default.
- Q65357322 P17 Q36 @default.
- Q65357322 P17 Q38 @default.
- Q65357322 P2899 "+2" @default.
- Q65357322 P3098 "NCT02141516" @default.
- Q65357322 P31 Q30612 @default.
- Q65357322 P4135 "+17" @default.
- Q65357322 P580 "2014-05-01T00:00:00Z" @default.
- Q65357322 P582 "2015-03-01T00:00:00Z" @default.
- Q65357322 P6099 Q42824827 @default.
- Q65357322 P8363 Q78089383 @default.